APEIRON Biologics AG is a company that provides Cancer immunotherapy, Biology, Pharmacy and Therapeutics and more. APEIRON Biologics AG is headquartered in Austria Wien. APEIRON Biologics AG was founded in 2005. APEIRON Biologics AG has a total of 255 patents and 1 literature
APEIRON is a focused on the discovery and development of novel cancer immunotherapies. APEIRON’s lead clinical program APN401 is a first-in-class autologous...